SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ

Bielpharma

Bielpharma Spółka z Ograniczoną Odpowiedzialnością

KRS: 0000857092NIP: 8822135807REGON: 386884178Share capital: 50.0 K PLN

Food manufacturing10.89.ZManufacture of other food products n.e.c.

UL. TKACKA, 17, 58-260, BIELAWA, POLSKA · View on map

Active

SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ

Bielpharma

Bielpharma Spółka z Ograniczoną Odpowiedzialnością

KRS: 0000857092NIP: 8822135807REGON: 386884178Share capital: 50.0 K PLN

Food manufacturing10.89.ZManufacture of other food products n.e.c.

UL. TKACKA, 17, 58-260, BIELAWA, POLSKA · View on map

Active

Financial statements - Bielpharma

Financial statements of Bielpharma - filed documents, filing punctuality and the full filing history in KRS 0000857092.

Financial statement details Bielpharma

5 statements available from the repository

2024

Jednostka inna | 366 days

2023

Jednostka inna | 365 days

2022

Jednostka inna | 365 days

2021

Jednostka inna | 365 days

2020

Jednostka inna | 126 days

Statement for fiscal year 2024

Period: January 1, 2024 - December 31, 2024 | Currency: PLN | Filed: October 5, 2025

Going concern declaredJednostkaInna

Income statement

Net revenue from sales

+7.7%20.9 K PLN

Operating expenses

-61.2%32.6 K PLN

Operating profit / (loss)

+81.8%-11.8 K PLN

Other operating income

-40.8%63.69 PLN

Other operating expenses

-30.3%108.72 PLN

Financial income

+81.8%-11.8 K PLN

Financial expenses

-82.0%67.56 PLN

Profit / (loss) before tax

+81.8%-11.9 K PLN

Income tax

+81.8%-11.9 K PLN

Net profit / (loss)

+81.8%-11.9 K PLN

Balance sheet

Total assets

+10.6%92.2 K PLN

Non-current assets

0 PLN

Current assets

+10.6%92.2 K PLN

Inventories

+38.9%66.8 K PLN

Short-term receivables

-65.7%11.7 K PLN

Cash and equivalents

+7899.2%13.7 K PLN

Total equity

-4.5%-273.3 K PLN

Share capital

0.0%50.0 K PLN

Liabilities and provisions

+6.0%365.5 K PLN

Long-term liabilities

+6.5%355.1 K PLN

Short-term liabilities

-7.7%10.4 K PLN

Provisions

0 PLN

Profit waterfall 2024

Revenue

20.9 K PLN

Operating costs

-32.6 K PLN

Operating profit

-11.8 K PLN

Other operating inc.

63.69 PLN

Other operating exp.

-108.72 PLN

Financial income

-11.8 K PLN

Financial costs

-67.56 PLN

Profit before tax

-11.9 K PLN

Income tax

11.9 K PLN

Net profit

-11.9 K PLN

Cost structure by nature

Materials and energy

6.3 K PLN

External services

20.7 K PLN

Taxes and fees

100 PLN

Other costs by nature

5.6 K PLN

Financial ratios (2024)

ROA

-12.85%

ROE

4.34%

Net margin

-56.74%

Operating margin

-56.42%

Gross margin

-56.74%

Current ratio

8.85

Cash ratio

1.31

Debt ratio

3.96

Debt / equity

-1.34

Asset turnover

0.23

Working capital

81.8 K PLN

Filings and compliance - Bielpharma

Latest reporting year

2024

Available years

20202021202220232024

Filing entries